Immune checkpoint skewing might be the cause of continuous immune activation in nasal polyps: New opportunities for therapies - 03/02/22
Doi : 10.1016/j.jaci.2021.11.003
Alex KleinJan, PhD ⁎ 
Department of Pulmonary Medicine, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
∗Corresponding author: Alex KleinJan, PhD, Department of Pulmonary Medicine, Erasmus Medical Center Rotterdam, Dr Molewaterplein 50, 3015 GE Rotterdam, The Netherlands.Department of Pulmonary MedicineErasmus Medical Center RotterdamDr Molewaterplein 50RotterdamThe Netherlands3015 GE
Key words : Autoimmunity, cAMP, chronic rhinosinusitis, immune checkpoints, nasal polyps, PDE4
Il testo completo di questo articolo è disponibile in PDF.
| Disclosure of potential conflict of interest: The author declares that he has no relevant conflicts of interest. |
© 2021
American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 149 - N° 2
P. 538-540 - Febbraio 2022 Ritorno al numero
Articolo precedente
- Moving beyond medication: Assessment and interventions on environmental and social determinants are needed to reduce severe asthma
- Erika Garcia, Frank Gilliland
- The importance of using core outcome measures during therapeutic studies of eosinophilic esophagitis
- David A. Hill
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?